Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis
NSE:JAGSNPHARM
VWAP
Open
Close
High
Low
52 Week High
-1.34 (-0.56%)
JAGSNPHARM
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: JAGSNPHARM Share Price Financial Analysis & Valuation
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs).
Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.
In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 1.68 per share. At the current share price of JAGSNPHARM at Rs 237.72, this results in a dividend yield of 0.71 %.
As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 7.8. NSE:JAGSNPHARM book value per share as of today is 43.84. The current price to book ratio for JAGSNPHARM as of Sep 09, 2026 is 5.42.
Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 31668% is very crucial parameter which shows that 31668% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at 238.72.
Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #1368:-
⇑ STRONG BUY JAGSNPHARM if All Greens
⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green
⇘ SELL JAGSNPHARM if NO Green Indicator
NSE: JAGSNPHARM Share Price Today (Sep 09, 2026)
(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)
Jagsonpal Pharmaceuticals Limited share price moved Down by -0.56% from its previous close of Rs 239.06. JAGSNPHARM stock last traded price is 237.72. JAGSNPHARM share price trend is Down with a total of 59503 stocks traded till now. It has touched an intraday high of Rs 241.33 and an intraday low of Rs 236.1. The JAGSNPHARM trading at 237.72, Down by Rs. -1.34, or -0.56 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down.
NSE: JAGSNPHARM Share Price Tomorrow Prediction
(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)
Jagsonpal Pharmaceuticals Limited share price moved Down by -0.56%. JAGSNPHARM share price short term trend is Down. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at 238.72 will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.
NSE Code |
NSE: JAGSNPHARM |
JAGSNPHARM Share Price Today |
237.72 |
JAGSNPHARM Share Price Target Prediction for 2026 ^ |
201.7 - 265.8 |
JAGSNPHARM Share Price Target Prediction for 2027*^ |
265.8 - 283.2 |
JAGSNPHARM Share Price Target Prediction for 2028*^ |
283.2 - 303 |
JAGSNPHARM Share Price Target Prediction for 2029*^ |
318 |
JAGSNPHARM Share Price Target Prediction for 2030*^ |
327 |
JAGSNPHARM Share Price Target Prediction for 2035*^ |
357 |
| JAGSNPHARM Current Book Value |
43.6 |
*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
JAGSNPHARM Technical Analysis
Candlestick Pattern: @239.63| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 239.74 | SELL | 239.45 | BUY |
| MA_12 | 236.28 | BUY | 237.21 | BUY |
| MA_20 | 235 | BUY | 235.58 | BUY |
| MA_32 | 231.72 | BUY | 232.7 | BUY |
| MA_50 | 231.82 | BUY | 229.32 | BUY |
| MA_100 | 221.23 | BUY | 222 | BUY |
| MA_200 | 202.66 | BUY | 214.25 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 235 | Uptrend |
| MACD | 0.39 | BUY |
| ADX | 36.27 | Strong Trend |
| DMI (+/-) | 26.32 / 11.13 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 57.02 | Neutral |
| STOCHASTIC_K (Fast) | 35.75 | Neutral |
| STOCHASTIC_D (Slow) | 35.23 | Neutral |
| CCI | 60.75 | Neutral |
| PSAR | 223.5 | BUY |
| TRUE RANGE | 7.07 | Neutral |
| ATR | 8.69 | Neutral |
| WILLIAMS R | -33.48 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 30.56 | Neutral |
| STOCHASTIC RSI D | 38.48 | Neutral |
| MOMENTUM | 4.26 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 2.47% |
| 3 Months | 18.86% |
| 1 Month | 1.81% |
| 1 Week | -0.75% |
| Action | Overall (%) |
|---|---|
| BUY | 63% |
| NEUTRAL / HOLD | 33% |
| SELL | 3% |
Most popular Questions & Answers about JAGSNPHARM (/ FAQ JAGSNPHARM)
Jagsonpal Pharmaceuticals Limited stock last traded price is 237.72. JAGSNPHARM share price moved Down by -0.56% from its previous close of Rs 239.06.
Jagsonpal Pharmaceuticals Limited share price trend is Down with a total of 59503 stocks traded till now. It has touched an intraday high of Rs 267.145 and an intraday low of Rs 236.1. The JAGSNPHARM trading at 237.72, Down by Rs. -1.34, or -0.56 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down and the Stop Loss will be around 238.72.
The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Sep 08, 2026.
The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Sep 08, 2026 is 34.5.
The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Sep 08, 2026 is 5.42.
The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹264.5 in the last 52-week.
The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹155 in the last 52-week.
Jagsonpal Pharmaceuticals Limited share trading at ₹237.72, Down by Rs. -1.34, or -0.56 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Down.
In 2026, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹201.7 on downside and ₹265.8 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹265.8 on downside and ₹283.2 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹283.2 on downside and ₹303 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹327 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.
The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by -0.56%. The short-term trend for JAGSNPHARM share price is Down. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 238.72 as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of JAGSNPHARM stock is 93.5. Compared to the current market price of 237.72 INR, the JAGSNPHARM stock is Overvalued by 60.7%.
As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 7.8. Jagsonpal Pharmaceuticals Limited book value per share as of today is 43.84. The current price to book ratio for JAGSNPHARM as of Sep 09, 2026 is 5.42.
NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price
Peer Comparison of NSE: JAGSNPHARM
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1885.90 | 16.35 | 97.89 |
| DIVISLAB | 9575.00 | 115.55 | 663.06 |
| MEDICAMEQ | 285.75 | 12.15 | 208.08 |
| CIPLA | 1384.00 | 51.67 | 434.03 |
| DRREDDY | 1151.00 | 53.19 | 380.63 |
| TORNTPHARM | 4960.00 | 87.32 | 235.7 |
| BIOCON | 392.30 | 1.27 | 166.51 |
| LUPIN | 2104.70 | 154.86 | 718.37 |
| ALKEM | 5181.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1692.00 | 46.49 | 403.84 |
| ABBOTINDIA | 25555.00 | 766.11 | 2448.41 |
| GLAXO | 2928.20 | 63.65 | 147.25 |
| IPCALAB | 1967.20 | 56.72 | 329.23 |
| LAURUSLABS | 1946.90 | 20.74 | 102.57 |
| LALPATHLAB | 1912.50 | 39.68 | 157.23 |
| PFIZER | 4310.70 | 170.54 | 963.41 |
| AJANTPHARM | 3579.30 | 89.3 | 363.23 |
| SANOFI | 3114.90 | 158.05 | 332.96 |
| NATCOPHARM | 825.75 | 82.14 | 481.67 |
| APLLTD | 808.50 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2474.50 | 1.24 | 881.78 |
| AAREYDRUGS | 98.03 | 2.39 | 53.38 |
| JUBLPHARMA | 997.75 | 4.35 | 145.63 |
| SPARC | 203.27 | 48.14 | 40.45 |
| GRANULES | 895.35 | 23.25 | 180.42 |
| ASTRAZEN | 6875.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2770.10 | 55.52 | 285.6 |
| FDC | 345.95 | 21.19 | 161.21 |
| HIKAL | 247.00 | 9.34 | 96.63 |